Anti-EGFR/BRAF-Tyrosine Kinase Inhibitors in Thyroid Carcinoma.
Papanikolaou V, Kyrodimos E, Mastronikolis N, Asimakopoulos AD, Papanastasiou G, Tsiambas E, Spyropoulou D, Katsinis S, Manoli A, Papouliakos S, Pantos P, Ragos V, Peschos D, Chrysovergis A.
Papanikolaou V, et al. Among authors: peschos d.
Cancer Diagn Progn. 2023 Mar 3;3(2):151-156. doi: 10.21873/cdp.10194. eCollection 2023 Mar-Apr.
Cancer Diagn Progn. 2023.
PMID: 36875315
Free PMC article.
Review.